The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Almirall Hermal GmbH; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Merck Serono; Merck Sharp & Dohme; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - 4SC; Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Incyte; LEO Pharma; Merck Serono; Merck Sharp & Dohme; Pierre Fabre; Roche/Genentech
Research Funding - Johnson & Johnson (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Pierre Fabre; Roche/Genentech
Adjuvant ipilimumab compared with observation in completely resected Merkel cell carcinoma (ADMEC): A randomized, multicenter DeCOG/ADO study.
 
J?Rgen C. Becker
Consulting or Advisory Role - Amgen; CureVac; Etherna; Lytix Biopharma; Merck KGaA; Novartis; Pfizer; RigonTEC; Takeda
Speakers' Bureau - Amgen; Merck KGaA; Pfizer
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck KGaA (Inst)
Travel, Accommodations, Expenses - 4SC; Merck KGaA; Pfizer
 
Jessica Cecile Hassel
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Merck Serono; MSD
Research Funding - 4SC (Inst); Amgen (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); Novartis (Inst); Philogen (Inst); Roche (Inst)
Travel, Accommodations, Expenses - MSD
 
Christian Menzer
No Relationships to Disclose
 
Katharina C. Kähler
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Roche
 
Thomas K. Eigentler
Consulting or Advisory Role - Bristol-Myers Squibb; Roche Pharma AG
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Roche Pharma AG
 
Friedegund Elke Meier
Honoraria - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche
 
Carola Berking
Honoraria - Amgen; LEO Pharma; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Galderma; Incyte; LEO Pharma; Merck Serono; MSD; Novartis; Pierre Fabre; Regeneron
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD
 
Ralf Gutzmer
No Relationships to Disclose
 
Peter Mohr
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche/Genentech
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis
 
Felix Kiecker
No Relationships to Disclose
 
Martin Kaatz
No Relationships to Disclose
 
Christiane Windemuth-Kieselbach
No Relationships to Disclose
 
Claudia Lorenz-Schlüter
No Relationships to Disclose
 
Lisa Zimmer
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre
 
Selma Ugurel
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Research Funding - Bristol-Myers Squibb (Inst); Medac; Merck Serono (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
 
Dirk Schadendorf
Honoraria - 4SC; Agenus; Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Grunenthal; Immunocore; Incyte; LEO Pharma; Merck Serono; Merck Sharp & Dohme; Mologen; Novartis; Pfizer; Philogen; Pierre Fabre; Regeneron; Roche/Genentech; Sysmex
Consulting or Advisory Role - 4SC; Amgen; Bristol-Myers Squibb; Immunocore; Incyte; Merck Serono; Merck Sharp & Dohme; Mologen; Novartis; Pierre Fabre; Roche/Genentech; Sanofi/Regeneron
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Incyte; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Roche/Genentech